NasdaqGM - Delayed Quote USD
NeuroPace, Inc. (NPCE)
Tune into live earnings calls Now streaming directly on quote pages.
12.89
+0.34
+(2.71%)
At close: May 9 at 4:00:00 PM EDT
12.89
0.00
(0.00%)
After hours: May 9 at 4:05:06 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -0.24 | -0.22 | -0.84 | -0.54 |
| Low Estimate | -0.31 | -0.26 | -0.95 | -0.84 |
| High Estimate | -0.17 | -0.15 | -0.54 | -0.2 |
| Year Ago EPS | -0.32 | -0.26 | -0.93 | -0.84 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 21.85M | 22.71M | 93.68M | 104.76M |
| Low Estimate | 21M | 22M | 92M | 98M |
| High Estimate | 22.96M | 23.29M | 96.02M | 114.31M |
| Year Ago Sales | 18.12M | 19.26M | 79.91M | 93.68M |
| Sales Growth (year/est) | 20.54% | 17.94% | 17.23% | 11.83% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.32 | -0.3 | -0.27 | -0.22 |
| EPS Actual | -0.32 | -0.26 | -0.19 | -0.18 |
| Difference | 0 | 0.04 | 0.08 | 0.04 |
| Surprise % | 0.47% | 13.39% | 29.33% | 19.40% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.22 | -0.84 | -0.54 |
| 7 Days Ago | -0.24 | -0.22 | -0.84 | -0.69 |
| 30 Days Ago | -0.24 | -0.22 | -0.84 | -0.69 |
| 60 Days Ago | -0.24 | -0.24 | -0.91 | -0.65 |
| 90 Days Ago | -0.25 | -0.23 | -0.9 | -0.56 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 4 | 3 | 1 | 3 |
| Up Last 30 Days | 4 | 4 | 4 | 3 |
| Down Last 7 Days | 1 | 1 | -- | -- |
| Down Last 30 Days | 1 | 1 | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NPCE | 26.48% | 13.77% | 9.96% | 35.25% |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 3/5/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/30/2025 |
| Initiated | UBS: Buy | 1/21/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 12/17/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 11/13/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/14/2024 |
Related Tickers
TMCI Treace Medical Concepts, Inc.
6.82
-9.55%
SGHT Sight Sciences, Inc.
3.0800
+1.65%
PHI1.HA Koninklijke Philips NV
21.77
+1.63%
PHIA.BE Koninklijke Philips NV
21.40
+1.90%
SERA Sera Prognostics, Inc.
2.2200
+4.72%
SIBN SI-BONE, Inc.
18.49
+0.87%
CLPT ClearPoint Neuro, Inc.
14.11
-0.98%
CVRX CVRx, Inc.
4.7700
-38.69%
XTNT Xtant Medical Holdings, Inc.
0.5047
-6.02%
TELA TELA Bio, Inc.
1.0800
+9.04%